Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Applied Optoelectronics has rallied into one of 2026's standout AI-supply winners, yet the stock has pulled back into key technical support ahead of an earnings cycle that should show continued top-line acceleration. The trade is a directional long sized for volatility: enter on weakness, use a pragmatic stop, and target a re-rating if revenue and …
Taysha Gene Therapies and Catalent have expanded their partnership to include commercial manufacturing support for Taysha's investigational gene therapy TSHA-102 targeting Rett syndrome. The agreement ensures long-term commercial manufacturing capacity at Catalent's FDA-licensed facility, supporting a potential U.S. launch pending FDA approval. Thi…
Powerus, through its subsidiary Tandem Defense, has secured a competitively awarded indefinite-delivery/indefinite-quantity contract from the U.S. Air Force with a ceiling value of up to $90 million through mid-2028. The contract covers Group 1 aerial-denial unmanned aircraft systems, including equipment, training, and field service support. This a…
Freedom Metals Acquisition Corp., a blank check company focused on mergers in the mining and critical minerals industry, announced that its Class A Ordinary Shares and Warrants will begin separate trading on Nasdaq starting August 4, 2026. Previously trading as combined units, shareholders can now trade shares under ticker FDMM and warrants under F…
GSI Technology, an innovator in Associative Processing Unit technology for AI and high-performance computing, announced its participation in the Needham Virtual Semiconductor & SemiCap Conference on August 19-20, 2026. Company executives will hold one-on-one meetings with institutional investors during the event to discuss their scalable, low-power…
VirTra, Inc., a global provider of use-of-force and firearms training simulators, will hold its second quarter 2026 earnings conference call on August 13, 2026, to discuss financial results for the period ended June 30, 2026. The company will issue a press release prior to the call, followed by a management presentation and Q&A session. This event …
KellyOCG, the outsourcing and consulting division of Kelly Services, has been named a global and U.S. leader in Everest Group's 2026 Recruitment Process Outsourcing (RPO) Services PEAK Matrix. This accolade reflects KellyOCG's integrated and scalable talent acquisition services supported by AI-powered technology such as its Sevayo platform and cons…
Altimmune, Inc. has initiated enrollment in the PERFORMA global Phase 3 clinical trial to evaluate the efficacy and safety of its lead drug candidate, pemvidutide, in patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced fibrosis. Building on positive Phase 2b IMPACT trial data demonstrating significant MASH…
Anavex Life Sciences Corp. disclosed plans to refresh its board with two new independent directors possessing deep life sciences and regulatory expertise. The company has established an Executive Committee to manage its business and emphasized focus on advancing its lead Alzheimer's candidate, oral blarcamesine (ANAVEX®2-73), across multiple CNS in…
Shoals Technologies Group announced a strategic memorandum of understanding with TerraFlow Energy to collaborate on developing and deploying up to 5 GW annually of grid-scale long-duration energy storage, combining TerraFlow's vanadium flow battery technology with Shoals' power distribution systems for utility-scale and data center applications. Th…
CytomX Therapeutics announced the appointment of Alejandra Carvajal as Chief Legal Officer. With over 20 years of legal expertise in biotech, Ms. Carvajal will aid in the company's strategic and operational initiatives as CytomX advances its oncology-focused PROBODY therapeutic pipeline. The company is focused on conditionally activated biologics f…
AgEagle Aerial Systems, traded as EagleNXT (NYSE: UAVS), announced the hiring of Lindsay A. Ryan, a 21-year U.S. Army aviation veteran, as Head of Sales and Business Development for their Counter-Unmanned Aircraft Systems (C-UAS) division. Ryan's extensive military experience and leadership in aviation are expected to drive sales growth and expand …
Akebia Therapeutics announced the initiation of a Phase 2 basket trial evaluating ebribafusp, a novel complement inhibitor designed to treat rare kidney diseases such as IgA nephropathy, lupus nephritis, and C3 glomerulopathy. The trial aims to demonstrate safety, efficacy, and pharmacokinetics through weekly subcutaneous dosing over 26 weeks, with…
eGain Corporation, recognized as a leader in Gartner's Magic Quadrant for Customer Service Knowledge Management Systems, presented its approach to AI governance emphasizing the importance of an accurate and governed knowledge layer, termed AI KnowledgeOps. Addressing recent AI containment breaches highlighted by OpenAI and Anthropic, eGain position…
Pelthos Therapeutics Inc., a biopharmaceutical company specializing in cutaneous infectious disease treatments, will report its second quarter 2026 financial results on August 13, 2026, followed by a conference call for investors and analysts. The company focuses on commercializing innovative topical therapies addressing unmet patient needs, includ…
Design Therapeutics reports progress in its RESTORE-FA trial with modifications based on positive four-week data, and expects 12-week data in Q1 2027. The company has also initiated dosing in a Phase 1 trial of DT-818 for myotonic dystrophy type 1, and continues development of multiple GeneTAC® programs targeting serious genetic diseases. Financial…
The Oncology Institute, one of the largest value-based oncology groups in the US, announced its rebranding to Starling Oncology, Inc. alongside a ticker symbol change to STLN on Nasdaq. The rebranding reflects the company's evolution into an integrated oncology platform, emphasizing accessibility, coordinated care, and a mission to address the cost…
Mesa Laboratories, Inc., a Nasdaq-listed company specializing in life science tools and quality control solutions, will announce its first quarter fiscal 2027 financial results on August 10, 2026, after market close. The company also plans to hold its inaugural earnings conference call on the same day to discuss financial details and answer analyst…
Cohen & Company Inc. reported robust financial results for Q2 2026, delivering net income of $3.6 million and adjusted pre-tax income of $10.1 million, both showing significant improvement compared to prior quarters. Driven primarily by their Capital Markets segment and successful SPAC activities, revenue increased to $69.5 million. The company dec…
electroCore, Inc., a bioelectronic medicine company, announced its participation in the Needham Virtual MedTech and Diagnostics Conference and the Canaccord Genuity Growth Conference in August 2026, with management presenting and holding one-on-one investor meetings.
Swarmer, Inc., a Nasdaq-listed drone autonomy software company, has announced a strategic partnership with Oak Grove Technologies (OGT) to integrate Swarmer's advanced autonomous swarm software with OGT's Chimera unmanned aircraft platform. This collaboration aims to enhance autonomous drone capabilities for U.S. Special Operations Forces, leveragi…
Neuronetics, Inc. disclosed a constructive agreement with Jorey Chernett, its second largest shareholder, affirming confidence in the company's financial health and management execution. The agreement includes a pathway for board representation, aimed at strengthening shareholder engagement. Major shareholder Madryn Asset Management also reaffirmed…
Carlsmed announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a reimbursement policy for inpatient aprevo® lumbar spinal fusion procedures under new MS-DRG codes in the FY27 IPPS Final Rule effective October 1, 2026. This reimbursement clarity is expected to expand hospital, surgeon, and patient access to aprevo® procedur…
Phillips Edison & Company, a leading US owner and operator of grocery-anchored neighborhood shopping centers, has launched an innovative AI-integrated corporate website. This website introduces AI-powered property search functionality, enabling brokers and retailers to use natural language prompts to find ideal retail spaces more efficiently. The i…
The U.S. State Department is formalizing a visa bond requirement for citizens of 50 countries applying for B1 and B2 visas, allowing consular officers to demand bonds of up to $20,000. The decision follows a 2025 pilot and is presented as a tool to curb visa overstays; critics say it will discourage legitimate travel and raise barriers to legal ent…
